Mr. Damien McCallion:

I understand that it is part of the quality assurance standard to look at the screeners and the individual performance, which would have been monitored. The point was made earlier that the Manchester screeners were in the returns for all of MedLab. That gave us assurance, at least, that the performance of the laboratory and of the screeners was being monitored and looked at as part of the ongoing process.